Multi-Omics Solutions
Genomics
Proteomics
Metabolomics
Human Genomics
Human genomics provides a powerful lens to understand the genetic foundation of health, development, and disease. By analyzing whole genomes or targeted regions, researchers and clinicians can uncover inherited disorders, predict disease risk, and tailor treatments to individual genetic profiles—paving the way for more effective and personalized healthcare solutions.
Precision Detection of Cancer-Driving Mutations
Precision oncology uses next-generation sequencing (NGS) to detect cancer-driving mutations and guide targeted treatment. NGS panels identify key genetic alterations—including SNVs, CNVs, fusions, and MSI—enabling diagnosis, therapy selection, and monitoring.
Key mutations and implications:
- EGFR, BRCA1/2, KRAS, BRAF V600E – Predict response to targeted therapies (e.g., TKIs, PARP inhibitors)
- ALK/ROS1/NTRK fusions – Indicate eligibility for fusion-specific inhibitors
- TP53 – Associated with aggressive disease and treatment resistance
- MSI-H/TMB-H/PD-L1 – Biomarkers for immunotherapy
- Clinical uses include liquid biopsy for MRD monitoring, comprehensive genomic profiling, and hereditary cancer risk assessment.
- NGS enables personalized cancer care, moving beyond one-size-fits-all chemotherapy to improve patient outcomes.
NGS enables precision neurology by detecting pathogenic variants across neurodevelopmental and neurodegenerative disorders, guiding diagnosis, treatment, and genetic counseling.
Key genes and implications:
- APP, PSEN1, PSEN2 – Alzheimer’s disease (familial forms, therapy guidance)
- LRRK2, GBA, SNCA – Parkinson’s disease (risk assessment, targeted trials)
- HTT – Huntington’s disease (diagnostic confirmation, progression)
- SCN1A, CDKL5 – Epilepsy and developmental encephalopathies (treatment selection)
- SOD1, C9ORF72 – ALS (patient stratification for therapy)
- NF1, NF2 – Neurofibromatosis (diagnosis and monitoring)
Clinical applications include whole-exome sequencing for unresolved cases, targeted panels for rapid diagnosis, mitochondrial genome analysis, and somatic variant detection in brain tumors.
NGS supports early intervention, personalized therapeutic strategies, and improved clinical outcomes in neurological care.
GI Health Screening: Genetics & Microbiome Insights
Genomic and molecular tools screen for inherited cancer risks, guide treatment, and evaluate gut health.
Key Screenings:
Genetic: Lynch syndrome, FAP, and NGS-based cancer panels
Microbiome: Gut flora analysis for inflammation, digestion, and nutrition
Risk factors: smoking, obesity, poor diet
Proactive screening enables early intervention and personalized care.
Pulmonology Screening: Breathe with Clarity
Genetic and molecular screening helps detect inherited lung conditions and guides personalized treatment for lung diseases.
Key Screenings:
Genetic: Cystic fibrosis (CFTR), Alpha-1 antitrypsin deficiency
Molecular: Lung cancer markers (EGFR, ALK, KRAS) for targeted therapy
Who Should Be Screened?
- Smokers or former smokers
- Chronic respiratory symptoms (cough, shortness of breath, wheezing)
- Family history of lung disease or genetic disorders
- Occupational exposure to pollutants or chemicals
- Autoimmune conditions with lung involvement
- Early screening supports proactive care and precision treatment.
Carrier screening is a genetic test that identifies hidden mutations for inherited disorders—even if you show no symptoms. It’s especially valuable for family planning, helping prospective parents understand their risk of having a child with a genetic condition.
Who Should Be Screened?
- Tests for gene mutations associated with hereditary disorders
- Carriers have one copy and are typically unaffected
- If both parents carry the same mutation, there’s a 25% chance their child will have the disorder
Empower your reproductive journey with knowledge and clarity.
Immunology screening evaluates immune system function to detect deficiencies, autoimmune disorders, allergies, and chronic inflammation. It identifies overactive, underactive, or misdirected immune responses, enabling early diagnosis and personalized treatment.
Who Should Be Screened?
- Recurrent or severe infections
- Unexplained fatigue, inflammation, or fever
- Family history of immune disorders
- Allergies, asthma, or eczema
- Patients on immunosuppressive therapies
Infectious disease screening uses advanced diagnostic tests to identify active or latent infections caused by pathogens like bacteria, viruses, fungi, or parasites. It is essential for early treatment, preventing transmission, and protecting public health—especially in high-risk, immunocompromised, or traveling populations.
Key Technologies:
- PCR/RT-PCR: Highly sensitive detection of pathogens
- NGS: Identifies rare/novel pathogens and tracks resistance genes
- Metagenomics: Analyzes complex or unexplained infections
Who Should Be Screened?
- Recurrent or severe infections
- Unexplained fatigue, inflammation, or fever
- Family history of immune disorders
- Allergies, asthma, or eczema
- Patients on immunosuppressive therapies
Personalized Wellness: Your Health, Your Blueprint
Personalized wellness is a modern approach to health that uses individual data—from genetics, microbiome, lifestyle, and biomarkers—to create tailored strategies for nutrition, exercise, stress management, and disease prevention. It moves beyond one-size-fits-all advice to deliver targeted recommendations that help you optimize your well-being, prevent chronic conditions, and live healthier, based on what your unique body needs.
Key pillars include:
🧬 Genetic insights
🦠 Gut microbiome analysis
📊 Blood biomarker tracking
🥗 Personalized nutrition & fitness plans
💊 Pharmacogenomics for medication safety
Animal Genomics
Animal genomics is the study of the genetic makeup of animals, focusing on the structure, function, and variation of their DNA. Using advanced tools like next-generation sequencing (NGS) and bioinformatics, researchers can analyze genomes to uncover the molecular basis of traits, behaviors, and diseases. This field has transformative applications in agriculture, conservation, and medicine, helping improve animal health, breeding strategies, and biodiversity preservation.
Selective Breeding: Animal genomics helps identify genes linked to traits like disease resistance, reproductive performance, and growth rate. This allows for genomic selection in breeding programs, improving livestock productivity and efficiency.
Disease Resistance: Genomic tools can identify animals with natural resistance to diseases (e.g., foot-and-mouth disease or avian influenza), leading to healthier herds and flocks.
Animal Welfare: Identifying genetic factors associated with stress, behavior, and health issues can improve livestock well-being.
Genetic Diversity Assessment: Genomic studies help assess the genetic diversity of endangered species, which is crucial for effective conservation management and making informed decisions about breeding programs.
Tracking Population Health: Monitoring genetic health in wild populations can help identify at-risk species or populations and assess how environmental changes or human activities affect genetic variability.
Genetic Disease Diagnosis: Animal genomics aids in identifying genetic mutations responsible for inherited diseases in pets and livestock. Early diagnosis allows for better management and treatment plans.
Personalized Medicine: Genomic data can tailor treatments to individual animals, improving the effectiveness of interventions and therapies.
Behavioral Genetics: Genomic analysis can uncover the genetic factors underlying behaviors in animals, ranging from feeding habits to mating preferences, helping researchers understand evolutionary processes.
Functional Genomics: Studying the regulation of gene expression and how genes control development, metabolism, and other biological processes helps us understand animal biology more deeply.
Behavioral Genetics: Genomic analysis can uncover the genetic factors underlying behaviors in animals, ranging from feeding habits to mating preferences, helping researchers understand evolutionary processes.
Functional Genomics: Studying the regulation of gene expression and how genes control development, metabolism, and other biological processes helps us understand animal biology more deeply.
Model Organisms: Many animals (e.g., mice, zebrafish) are used as model organisms to study human diseases. Animal genomics allows for better understanding of disease pathways and the development of new treatments.
Transgenic Animals: Genetically modified animals are used to study gene function or produce pharmaceuticals (e.g., genetically engineered goats producing therapeutic proteins in their milk).